Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis.
Phase 2 BOLD extension study efficacy results for siponimod (BAF312) in patients with relapsing-remitting multiple sclerosis.
Inclusion of brain volume loss in a revised measure of 'no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis.
Receptos Reports Positive Phase 2 Results for TOUCHSTONE Trial of RPC1063 in Ulcerative Colitis
Microglia activation is associated with IFN-α induced depressive-like behavior.
Modulation of dendritic cell properties by laquinimod as a mechanism for modulating multiple sclerosis.
Laquinimod for multiple sclerosis.
Epidemiology of multiple sclerosis in Australia. With NSW and SA survey results.
Epigenetic mechanisms in multiple sclerosis and the major histocompatibility complex (MHC).
GeNeuro and Servier sign partnership to develop first medicine addressing a causal factor of multiple sclerosis
Laquinimod
Effects of idebenone (CV-2619) and its metabolites on respiratory activity and lipid peroxidation in brain mitochondria from rats and dogs.
The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community.
Prolonged Toxic Encephalopathy following Accidental 4-Aminopyridine Overdose.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
Proof-of-concept, randomized, controlled clinical trial of Bacillus-Calmette-Guerin for treatment of long-term type 1 diabetes.
Receptos, Inc. - Current Report: United States Securities and Exchange Commission Form 8-K
Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study.
Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: A randomized controlled clinical trial.
Prolonged Remission in Neuromyelitis Optica Following Cessation of Rituximab Treatment.
Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1.
Clinical and MRI characterization of MS patients with a pure and severe cognitive onset.
Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2.
US top court denies Israel's Teva Pharmaceuticals stay in Copaxone patent fight
The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.

Pages